CN105154405B - A kind of colorectal cancer cell primary culture method of low damage - Google Patents

A kind of colorectal cancer cell primary culture method of low damage Download PDF

Info

Publication number
CN105154405B
CN105154405B CN201510647527.8A CN201510647527A CN105154405B CN 105154405 B CN105154405 B CN 105154405B CN 201510647527 A CN201510647527 A CN 201510647527A CN 105154405 B CN105154405 B CN 105154405B
Authority
CN
China
Prior art keywords
culture
tissue
antibiotic
colorectal cancer
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201510647527.8A
Other languages
Chinese (zh)
Other versions
CN105154405A (en
Inventor
赵增仁
翟从劼
张峰
姜霞
唐宇杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FIRST HOSPITAL OF HEBEI MEDICAL UNIVERSITY
Original Assignee
FIRST HOSPITAL OF HEBEI MEDICAL UNIVERSITY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FIRST HOSPITAL OF HEBEI MEDICAL UNIVERSITY filed Critical FIRST HOSPITAL OF HEBEI MEDICAL UNIVERSITY
Priority to CN201510647527.8A priority Critical patent/CN105154405B/en
Publication of CN105154405A publication Critical patent/CN105154405A/en
Application granted granted Critical
Publication of CN105154405B publication Critical patent/CN105154405B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to a kind of colorectal cancer cell primary culture methods of low damage comprising following steps: (1) organizing pre-treatment: by Colorectal Carcinoma through antibiotic treatment;(2) stripping and slicing;(3) it cultivates: the tissue block cut being put into antibiotic culture medium and carries out initial-stage culture and normal culture, until cell is adherent.Method of the invention is small to cellular damage, cell survival rate is high, easy culture easy to operate.

Description

A kind of colorectal cancer cell primary culture method of low damage
Technical field
The invention belongs to technical field of cell culture, and in particular to a kind of colorectal cancer cell originally culture side of low damage Method.
Background technique
Colorectal cancer is common alimentary system malignant tumour, and the morbidity and mortality of China's colorectal cancer are in recent years Rise year by year trend.Most colorectal cancer patients have belonged to middle and advanced stage when medical, treatment cost is big, effect is poor, long term survival rate is low. Heavy burden is brought to patient, family and society simultaneously.Colorectal cancer have obvious cancer before and cancer early lesion, And the time was up to for more than ten years.This provides chance for the early detection of colorectal cancer and precancerous lesion and early treatment.Tumour mark The measurement of will object plays an important role in terms of the diagnosis of tumour, curative effect evaluation, detection recurrence and supposition, to raising Clinical tumor treatment level has great importance.
Colorectal cancer is polygenes change procedure, and unique identification object screening specificity and sensibility are lower, it is difficult to Cope with the screening of large sample crowd.Although many for the research in terms of colorectal cancer tumor markers both at home and abroad, at present Applied to clinical colorectal cancer tumor markers --- CEA, CA199, CA125, CA724 etc. still lack enough sensitivitys and Specificity finds the new tumor marker closely related with colorectal cancer development process, to early diagnosis and intervenes Colon and rectum Cancer is of great significance.But so far, it is straight not yet to find that not only sensitive but also special tumor markers can be applied to clinical knot The detection of intestinal cancer.Therefore, effective tumor markers are found as primary dcreening operation means, progress colorectal cancer early screening, early stage diagnosis and treatment To block or delay colorectal cancer progress, improve patient's prognosis and extend life cycle be of great significance.
By the high flux screening for expressing Colorectal Carcinoma cell and normal Colon and rectum mucomembranous cell albumen, it is possible to It was found that the difference of tumor tissues and normal mucosa histocyte protein expression profiles, and then find new tumor markers.It is high-throughput The albumen of screening tumor cells expression then needs to be related to the originally culture of tumour cell, and this research method is to primary training The fostering requirement for supporting cell is very high, and Yao Jinliang avoids caused cell rupture or cell membrane damage in experimental implementation.
Originally culture is to be cultivated immediately after directly removing cell, tissue and organ from body, in colorectal cancer In research, the originally culture of cancer cell has not been reported directly to be grown using mechanical crushing method, is all made of traditional enzyme digestion, Machinery is carried out to Colorectal Carcinoma early period to shred, enzymic digestion then is added into the tissue shredded, is dispersed into it individually Cell.
Traditional enzyme digestion has the disadvantage that (sample can only be selected identical due to digestion time The time is handled, for example bigger tissue block is digested to single cell as standard formulation digestion time, is necessarily caused lesser The digestion of tissue block and free cell is excessive), it will cause cell dissociation and unevenly even digest excessively, damaging cells film destroys Cell influences cell activity, or digestion is not thorough the progress for being unfavorable for high flux screening experiment;Enzyme it is many kinds of, disappearing Select the type of enzyme and concentration that there is variability when change, different its requirement to enzyme of tissue are also different, need the item of complexity Part is groped.
Summary of the invention
Defect based on the prior art, the technical problem to be solved by the invention is to provide a kind of pair of cellular damage is small, thin Born of the same parents survival rate is high, the low damage easy to operate easily cultivated colorectal cancer cell primary culture method.
The technical scheme adopted by the invention to solve the technical problem are as follows: a kind of colorectal cancer cell originally culture of low damage Method comprising following steps:
(1) tissue pre-treatment: by Colorectal Carcinoma through antibiotic treatment;
(2) stripping and slicing;
(3) it cultivates: the tissue block cut being put into antibiotic culture medium and carries out initial-stage culture and normal culture, until Cell is adherent.
Further, step (1) rinses Colorectal Carcinoma with sterile saline, is then placed in antibiotic nothing Blood serum medium impregnates.
Further, antibiotic in the antibiotic serum free medium are as follows: 500 U/mL penicillin, 500 μ G/mL streptomysin, 1.25 μ g/mL amphotericin Bs, 80 μ g/mL gentamicins.
Further, step (2) stripping and slicing are as follows: tissue block is put into Tissue Culture Dish, is cut tissue with aseptic operation knife It is broken to volume 1-50mm3, preferably 15-30mm3
Further, step (3) initial-stage culture uses initial-stage culture base, contains: volume fraction is 10% tire ox blood Clearly;100 U/mL penicillin;100 μ g/mL streptomysins;0.25 μ g/mL amphotericin B;80 μ g/mL gentamicins; 2mmol/L glutamine.
Further, step (3) the normal culture uses normal incubation medium, and contain: volume fraction is 10% tire ox blood Clearly;100 U/mL penicillin;100 μ g/mL streptomysins;0.25 μ g/mL amphotericin B;2 mmol/L glutamine.
Further, -80 DEG C of precooled Tissue Culture Dish are used when step (2) stripping and slicing;When organizing stripping and slicing, cell is trained Feeding ware is placed on ice, and tissue block is placed in Tissue Culture Dish, and low-temperature operation can delay cell metabolism procedure, thus relatively long Ground saves organizational vitality, effectively avoid tissue in vitro after ischemic, cell caused by anoxic.
Further, while the tissue of step (1) is through antibiotic treatment, through interleukin 6 inhibitor immersion treatment.
Specifically include following operating procedure:
(1) tissue pre-treatment: Colorectal Carcinoma is chosen, sterile saline rinses 30s or more, with highly concentrated with 4 kinds The serum-free RPMI-1640 culture medium for spending antibiotic and interleukin 6 inhibitor impregnates;After 5-10min, replace fresh containing high concentration 5-10min is impregnated again after the serum-free RPMI-1640 culture medium of antibiotic.In soaking process, rock frequently, it is reverse to rock, 6 Beat/min, more preferably to contact with each other and clean;Interleukin 6 inhibitor selects Siltuximab in soak, and concentration is 1-15 μ G/mL, preferably 11 μ g/mL;
This step operation can neutralize the interleukin 6 in necrotic tissue, reduce the cellular damage of its mediation, while this is operated Reduce the materials standard of tissue;Necrotic tissue is less than the one third of sample total volume, and conventional method requires to avoid bad Dead tissue, with the progress of medicine, for the clinical materials for the object that swell from now on just vulnerable to limitation, reducing materials standard to be undoubtedly is scientific research Work provides premise and guarantee, substantially increases originally culture success rate;
4 kinds of antibiotic concentrations in step (1):
500 U/mL penicillin,
500 μ g/mL streptomysins,
1.25 μ g/mL amphotericin Bs,
80 μ g/mL gentamicins;
(2) stripping and slicing: tissue block is put into -80 DEG C of precooled Tissue Culture Dish, when organizing stripping and slicing, by Tissue Culture Dish It is placed on ice, tissue block is placed in Tissue Culture Dish, with aseptic operation knife minced tissue to volume 1-50mm3, preferably 15- 30mm3
(3) without culture medium culture: pure blood is clear and rich to wash culture bottle, and tissue block is placed directly into culture bottle, and tissue cultures rise The 3h of beginning does not add culture medium, in order to accelerate adherent and adherent stronger, after 3h, adhere to culture to tissue block It on bottle, then adds 1mL pure blood and is cultivated clearly, pure serum free culture system is for 24 hours;
(4) initial-stage culture: being 10% fetal calf serum, 4 kinds of Antibiotics of Low Concentration and 2 mmol/L paddy ammonia with containing volume fraction The RPMI-1640 culture medium of amide continues to cultivate 48-72h, wherein 4 kinds of Antibiotics of Low Concentration:
100 U/mL penicillin,
100 μ g/mL streptomysins,
0.25 μ g/mL amphotericin B,
80 μ g/mL gentamicins;
(5) normal culture: being 10% fetal calf serum, 3 kinds of antibiotic and 2 mmol/L glutamine with containing volume fraction RPMI-1640 culture medium changes liquid Nostoc commune Vanch, changes liquid within every 5-7 days;Observe the adherent situation of cell;3 kinds of Antibiotics of Low Concentration:
100 U/mL penicillin,
100 μ g/mL streptomysins,
0.25 μ g/mL amphotericin B;
(6) after confirmation cell is adherent, primary part observation culture changes liquid according to concrete condition.
RPMI-1640 culture medium of the invention is this field common culture medium, and for details, reference can be made to " E16.5 mice embryonic pancreases Glandular tissue transplantation treatment artificial diabetes ", Chinese of Journal General Surgery, in September, 2013, the 9th phase of volume 28.
The beneficial effects of the present invention are:
(1) it when materials, does not need deliberately to avoid necrotic tissue, improves materials efficiency, avoid waste of material;
(2) tissue block is put into Tissue Culture Dish, with aseptic operation knife minced tissue, reduces the machinery to tissue block Damage, in addition, the tissue block size requirements to chopping are not stringent, conventional method requires chopping to 1 mm3Hereinafter, this method volume Biggish tissue block can also reach culture effect, and 15-30mm3Tissue block effect ratio 1mm3More preferably;
(3) according to the special generation environment of Colorectal Carcinoma, specific antibiotic concentration is configured, and according to cancer cell Growth cycle characteristic changing concentration and type, be conducive to inhibit tissue in bacterial reproduction, avoid cell microbiological contamination, improve patch Wall rate;
(4) serum rinse culture bottle and 3h no liquid culture promote quick wall attaching;First day quickening tissue of pure serum free culture system Adaptation to vitro culture conditions;
(5) glutamine guarantees fissional raw material supply.
The present invention carries out originally culture to Colorectal Carcinoma using mechanical stripping and slicing, the specific culture solution of cooperation, avoids The high risk of tradition machinery breaking method contamination rate also avoids damage of the enzyme digestion to cell, ensure that greatest extent The integrality of cell is realized and is quickly repaired.Inventor is also found surprisingly that in test the culture incipient stage carries out 3h no liquid Culture, can accelerate the speed of tissue block adherent, and make adherent stronger, and tissue block is not easily to fall off, can accelerated cell growth. Acute inflammation and necrotic tissue situation are complicated in Colorectal Carcinoma, and the addition of interleukin 6 inhibitor is deposited when can permit materials In necrotic tissue.
Detailed description of the invention
Fig. 1 is 1 microscopically observation result of embodiment;
Fig. 2 is comparative example microscopically observation result.
Specific embodiment
In order to make the foregoing objectives, features and advantages of the present invention clearer and more comprehensible, implement below in conjunction with the present invention Specific embodiment in example, technical scheme in the embodiment of the invention is clearly and completely described, it is clear that described Embodiment be only a part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, ability Domain those of ordinary skill every other embodiment obtained without making creative work, belongs to guarantor of the present invention The range of shield.
Embodiment 1
A kind of colorectal cancer cell primary culture method of low damage of embodiment 1 comprising following steps:
(1) tissue pre-treatment: Colorectal Carcinoma is chosen, sterile saline rinses 30s or more, with highly concentrated with 4 kinds The serum-free RPMI-1640 culture medium for spending antibiotic and interleukin 6 inhibitor impregnates;After 5-10min, replace fresh containing high concentration 5-10min is impregnated again after the serum-free RPMI-1640 culture medium of antibiotic;In soaking process, rock frequently, it is reverse to rock, 6 Beat/min, more preferably to contact with each other and clean;Interleukin 6 inhibitor selects Siltuximab in soak, and interleukin 6 inhibits Johson & Johnson's production is selected in agent, and concentration is 11 μ g/mL;
This step operation can neutralize the interleukin 6 in necrotic tissue, reduce the cellular damage of its mediation, while this is operated Reduce the materials standard of tissue;Necrotic tissue is less than the one third of sample total volume, and conventional method requires to avoid bad Dead tissue, with the progress of medicine, for the clinical materials for the object that swell from now on just vulnerable to limitation, reducing materials standard to be undoubtedly is scientific research Work provides premise and guarantee, substantially increases originally culture success rate;
4 kinds of antibiotic concentrations:
500 U/mL penicillin,
500 μ g/mL streptomysins,
1.25 μ g/mL amphotericin Bs,
80 μ g/mL gentamicins.
(2) stripping and slicing: tissue block is put into -80 DEG C of precooled Tissue Culture Dish, when organizing stripping and slicing, by Tissue Culture Dish It is placed on ice, tissue block is placed in Tissue Culture Dish, with aseptic operation knife minced tissue to volume 15mm3
(3) without culture medium culture: pure blood is clear and rich to wash culture bottle, and tissue block is placed directly into culture bottle, and tissue cultures rise The 3h of beginning does not add culture medium, in order to accelerate adherent and adherent stronger, after 3h, adhere to culture to tissue block It on bottle, then adds 1mL pure blood and is cultivated clearly, pure serum free culture system is for 24 hours.
(4) initial-stage culture: being 10% fetal calf serum, 4 kinds of Antibiotics of Low Concentration and 2 mmol/L paddy with containing volume fraction The RPMI-1640 culture medium of glutamine continues to cultivate 48-72h, wherein 4 kinds of Antibiotics of Low Concentration:
100 U/mL penicillin,
100 μ g/mL streptomysins,
0.25 μ g/mL amphotericin B,
80 μ g/mL gentamicins.
(5) normal culture: being 10% fetal calf serum, 3 kinds of antibiotic and 2 mmol/L glutamine with containing volume fraction RPMI-1640 culture medium changes liquid Nostoc commune Vanch, changes liquid within every 5-7 days;Observe the adherent situation of cell;3 kinds of Antibiotics of Low Concentration:
100 U/mL penicillin,
100 μ g/mL streptomysins,
0.25 μ g/mL amphotericin B.
(6) after confirmation cell is adherent, primary part observation culture changes liquid according to concrete condition.
RPMI-1640 culture medium of the invention is this field common culture medium, and for details, reference can be made to " E16.5 mice embryonic pancreases Glandular tissue transplantation treatment artificial diabetes ", Chinese of Journal General Surgery, in September, 2013, the 9th phase of volume 28.
Embodiment 2
When 2 difference from Example 1 of embodiment is step (1) tissue pre-treatment, interleukin 6 inhibitor The concentration of Siltuximab is 1 μ g/mL;Step (2) stripping and slicing is to volume 50mm3
Embodiment 3
When 3 difference from Example 1 of embodiment is step (1) tissue pre-treatment, interleukin 6 inhibitor The concentration of Siltuximab is 15 μ g/mL;Step (2) stripping and slicing is to volume 1mm3
Embodiment 4
4 difference from Example 1 of embodiment is step (2) stripping and slicing to volume 30mm3
Comparative example
The primitive cell culture of Colorectal Carcinoma is carried out using enzyme digestion, concrete operations are as follows:
1、1-2cm3Tissue block is put into Tissue Culture Dish, is added 10mL RPMI-1640 culture medium (serum-free), with height Pressure sterilizing operating scissors removal nonneoplastic tissue and necrotic tissue;
2, tissue is transferred in new culture dish, is cut into small pieces.20mL RPMI-1640 culture medium (serum-free) resuspension group It knits block and is transferred in 50mL conical pipe.Room temperature, 1200rpm 6min abandon supernatant;
3, tissue, 37 DEG C of digestion 4hr, with stirring are resuspended in 10mL Tumor Cell Digestion Solution;
4,10mL Tumor Cell Suspension Solution is added and puts out mixing.The filtering of 100mm filter is mixed Suspension collects filtrate into a clean 50mL conical pipe;
5, room temperature, 1200rpm 8min abandon supernatant.It is resuspended with 20mL Tumor Cell Suspension Solution Precipitating mixes, obtains the cell mixture of mean value;
6, it is added in the new 50mL conical pipe of 20mL Tumor Cell Purification Solution to one, is labeled as Pipe A, room temperature 1200rpm 2min;
7, gained 20mL cell suspension in 5 is placed in the solution upper layer of pipe A;
8, pipe A is vertically stood into 6min in room temperature;
9, pipetting tip is carefully protruded into conical pipe bottom, siphons away 6mL Tumor Cell Purification from bottom Solution moves in a new 50mL conical pipe, is designated as pipe B;
10,1200rpm 8min abandons supernatant;
11, (volume fraction is 10% fetal calf serum, 100 U/mL penicillin, 100 μ g/ to 5mL RPMI-1640 culture medium ML streptomysin) precipitating is resuspended;
12, cell is moved to a hole of 6 orifice plates, is cultivated 3-4 days.
Effect example
By same Colorectal Carcinoma, the method that embodiment 1 and comparative example is respectively adopted carries out originally culture, comparative example warp Step 12 processing, culture have no cell Proliferation for 3-4 days, are compared after normal culture 20 days after culture 20 days with embodiment 1, As a result as shown in Figure 1, Figure 2 and table 1.
The cultivation results of table 1 embodiment 1 and comparative example
By comparison, it was found that:
Kit (enzyme digestion) is more demanding to tissue block, and complex for operation step, operation takes a long time, in vitro from tissue To starting to cultivate, 6-7h is needed, tumor tissues are detached from the environment of suitable growth for a long time.In terms of final result, when enzymic digestion pair The damage of tissue is very big, and final gained cell quantity seldom (less than the 5/visual field), far can not reach the number of cell culture Amount, and the structure of gained cell has obvious damage, is not able to satisfy experiment demand.
Method of the invention only need to tentatively shred tissue block, and not stringent to the size requirements of tissue block, Reduce shearing number, alleviate the mechanical damage degree to tissue block, then disappears without carrying out enzyme to the tissue block after shearing Change, further reduces the damage to cell.After preliminary immersion shearing, it can be cultivated, be cultivated in vitro since tissue, 0.5h is not exceeded, reduces tumor tissue cell to greatest extent in the time of non-suitable growth environment.In terms of final result, After the processing of equiponderant tissue block, cell quantity is more than traditional enzyme digestion (more than the 70/visual field) under same field of view, can be with Meet experiment demand in next step.

Claims (4)

1. a kind of colorectal cancer cell primary culture method of low damage, which is characterized in that it includes the following steps:
(1) tissue pre-treatment: by Colorectal Carcinoma through antibiotic treatment, while through interleukin 6 inhibitor immersion treatment;
(2) stripping and slicing;
(3) it cultivates: first carrying out no culture medium culture, pure blood is clear and rich to wash culture bottle, and tissue block is placed directly into culture bottle, tissue The 3h for cultivating starting, does not add culture medium, after 3h, adheres on culture bottle to tissue block, then add 1mL pure blood and trained clearly It supports, pure serum free culture system is for 24 hours;It is then placed in antibiotic culture medium and carries out initial-stage culture and normal culture, until cell is adherent;
Step (3) the primary culture uses primary culture medium, and it is 10% fetal calf serum, 4 that primary culture medium, which is containing volume fraction, The RPMI-1640 culture medium of kind Antibiotics of Low Concentration and 2mmol/L glutamine, wherein 4 kinds of Antibiotics of Low Concentration are 100 U/ ML penicillin, 100 μ g/mL streptomysins, 0.25 μ g/mL amphotericin B, 80 μ g/mL gentamicins;
Step (3) the normal culture uses normal incubation medium, and it is 10% fetal calf serum, 3 that normal incubation medium, which is containing volume fraction, The RPMI-1640 culture medium of kind of antibiotic and 2 mmol/L glutamine, wherein 3 kinds of antibiotic be 100 U/mL penicillin, 100 μ g/mL streptomysins, 0.25 μ g/mL amphotericin B.
2. the colorectal cancer cell primary culture method of low damage according to claim 1, which is characterized in that step (1) Colorectal Carcinoma is rinsed with sterile saline, antibiotic serum free medium is then placed in and impregnates.
3. the colorectal cancer cell primary culture method of low damage according to claim 2, which is characterized in that described containing anti- Antibiotic in the serum free medium of raw element are as follows: 500 U/mL penicillin, 500 μ g/mL streptomysins, 1.25 μ g/mL both sexes Mycin B, 80 μ g/mL gentamicins.
4. the colorectal cancer cell primary culture method of low damage according to claim 1, which is characterized in that step (2) Stripping and slicing are as follows: tissue block is put into Tissue Culture Dish, is shredded tissue to volume 15-30mm with aseptic operation knife3
CN201510647527.8A 2015-10-09 2015-10-09 A kind of colorectal cancer cell primary culture method of low damage Expired - Fee Related CN105154405B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510647527.8A CN105154405B (en) 2015-10-09 2015-10-09 A kind of colorectal cancer cell primary culture method of low damage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510647527.8A CN105154405B (en) 2015-10-09 2015-10-09 A kind of colorectal cancer cell primary culture method of low damage

Publications (2)

Publication Number Publication Date
CN105154405A CN105154405A (en) 2015-12-16
CN105154405B true CN105154405B (en) 2019-04-05

Family

ID=54795452

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510647527.8A Expired - Fee Related CN105154405B (en) 2015-10-09 2015-10-09 A kind of colorectal cancer cell primary culture method of low damage

Country Status (1)

Country Link
CN (1) CN105154405B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108396010A (en) * 2017-02-06 2018-08-14 王琼 A kind of extracorporeal culturing method of colorectal cancer organoid
CN108103023A (en) * 2018-02-01 2018-06-01 河北医科大学第医院 People's carcinoma of the rectum primary cell and its application
CN108192871A (en) * 2018-02-01 2018-06-22 河北医科大学第医院 People's carcinoma of the rectum primary cell and its application
CN108192872A (en) * 2018-02-01 2018-06-22 河北医科大学第医院 People's carcinoma of the rectum primary cell and its application
CN108103024A (en) * 2018-02-01 2018-06-01 河北医科大学第医院 People's carcinoma of the rectum primary cell and its application
CN110592018A (en) * 2018-06-13 2019-12-20 北京吉尚立德生物科技有限公司 Method for culturing primary cells of colorectal cancer solid tumors
CN110029089A (en) * 2019-04-29 2019-07-19 北京和合医学诊断技术股份有限公司 Serum free medium, preparation method and the method for cultivating primary tumor cell

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0911389A2 (en) * 1997-08-29 1999-04-28 University Of Pittsburgh Of The Commonwealth System Of Higher Education Epithelial cell cultures for in vitro testing
CN103243074A (en) * 2012-02-14 2013-08-14 中国科学院动物研究所 Human colorectal adenocarcinoma tumor cell line as well as preparation method and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0911389A2 (en) * 1997-08-29 1999-04-28 University Of Pittsburgh Of The Commonwealth System Of Higher Education Epithelial cell cultures for in vitro testing
CN103243074A (en) * 2012-02-14 2013-08-14 中国科学院动物研究所 Human colorectal adenocarcinoma tumor cell line as well as preparation method and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
The challenge of culturing human colorectal tumor cells: establishment of a cell culture model by the comparison of different methodological approaches;Alessandra Failli等;《Tumori》;20091231;第344页左栏最后一行 *
简便人大肠癌原代细胞培养方法的探讨;蔡慧云 等;《临床军医杂志》;20110831;第39卷(第4期);第1.2.1-1.2.2节、第2.1节、表1 *
蔡慧云 等.简便人大肠癌原代细胞培养方法的探讨.《临床军医杂志》.2011,第39卷(第4期),第1.2.1-1.2.2节、第2.1节、表1. *

Also Published As

Publication number Publication date
CN105154405A (en) 2015-12-16

Similar Documents

Publication Publication Date Title
CN105154405B (en) A kind of colorectal cancer cell primary culture method of low damage
TW200521234A (en) Method of single cell culture of undifferentiated human embryonic stem cells
CN101627701A (en) Method for breeding cordyceps militars strain
CN106092677A (en) Sweet potato and relative genus plant cell division phases sample fast preparation method thereof
CN108977367B (en) Aspergillus niger strain and application thereof in degradation of tea saponin in camellia oleifera cake
CN113151177B (en) Breast or breast cancer tissue acellular matrix and preparation method and application thereof
CN102978154B (en) Primary culture method for simultaneously separating skin fibroblasts and epidermis cells of Inner mongolia white cashmere goat
JP2005533512A (en) Method for producing extracellular matrix and its use for tumor cell culture
CN109628394A (en) A method of extraction umbilical cord mesenchymal stem cells of the grinding in conjunction with mixed enzyme
WO2022068029A1 (en) Special culture apparatus for 3d biological tissue, and method for preparing block-shaped cultured meat
CN101654667A (en) Method for establishing lactation model of cow mammary gland epithelial cells
CN115975817A (en) Ganoderma lucidum strain L5478 and artificial cultivation method thereof
CN112725377B (en) Application of resveratrol in electroporation transfected cells and electrotransfection liquid
CN105624103A (en) Improved separation preparation method for mouse thoracic aorta vascular smooth muscle cells
CN106754672A (en) A kind of cultural method of attached cell
CN205803502U (en) A kind of tumor stem cell culture dish
CN103602630A (en) In vitro culture method of cervical intraepithelial neoplasia cells
CN105724550B (en) A method of carrying out fish scrap bone and flesh separation using microbial fermentation
CN112941183B (en) Application of non-coding gene miR-187-5p in primary liver cancer diagnosis and treatment
TW201018724A (en) Rhizopus spp., the culture method and the application thereof
CN113174370B (en) Cord blood stem cell and amplification culture method thereof
CN112056463B (en) Application of anemonin in improving quality of beef
CN114934089B (en) Biological agent for lean pork pig breeding
CN107119010B (en) Synthetic adhesion culture medium for cell culture and preparation method thereof
CN101955884B (en) Device for separating primary cells from tissue

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20190405

Termination date: 20201009

CF01 Termination of patent right due to non-payment of annual fee